Dr. Richard Youatt-Declan Fleming, MD

Dr. Fleming practices at UT Health Austin Ambulatory Surgery Center in Austin, Texas.

Dr. Fleming's NPI, 1881623114, was assigned on June 30, 2006. Dr. Fleming graduated from UTMB Health in 1988. Dr. Fleming's Texas license number on file is H7055.

Dr. Fleming's primary practice is UT Health Austin Ambulatory Surgery Center, at 1601 Trinity St. Htb Bldg. A, Austin, TX 78712. The practice phone is (512) 855-3522.

Dr. Fleming's primary practice is UT Health Austin Ambulatory Surgery Center in Austin, Texas. Dr. Fleming is also affiliated with Dell Seton Medical Center at The University of Texas. The medical group on file is UT Health Austin. Dmand AI also links Dr. Fleming to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fleming practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Fleming's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Fleming is board certified in surgery by the American Board of Surgery. Dr. Fleming has a license on file in Texas.

Dmand AI lists colon removal among the conditions Dr. Fleming treats.

CMS data shows 111 Medicare services from Dr. Fleming across 3 procedure codes in 2024, all of them office visits, for 96 Medicare patients. Medicare paid $7,727 for them. Every service was in an office.

CMS counts 96 Medicare patients who saw Dr. Fleming in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fleming's median patient age at 71, with 57% women.

In 2024, Dr. Fleming wrote 42 Medicare Part D claims for 16 patients. 67% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $31 in total drug cost. In 2019, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Fleming for performance year 2024, reported as part of a group. Dr. Fleming accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fleming as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Fleming, published from 2020 to 2022. Dr. Fleming's most frequent co-author is J Stuart Wolf, MD.

Dmand AI links Dr. Fleming to 1 clinical trial. Conditions studied include Colonic Neoplasms and Inflammatory Bowel Diseases.

CMS Open Payments shows 49 general payments to Dr. Fleming from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 39% of the total. Covidien LP paid the most, $6,810. It also lists 1 research payment totaling $500 in 2016.

Dmand AI lists 1 award for Dr. Fleming, most recently CMS Stage 1 2012 in 2012.

Dr. Fleming graduated from UTMB Health in 1988.

Dr. Fleming is in network with 20 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.